London · Delayed Price · Currency is GBP · Price in GBX Exscientia Statistics
Total Valuation
Dr. Martens has a market cap or net worth of GBP 755.22 million. The enterprise value is 1.00 billion.
| Market Cap | 755.22M |
| Enterprise Value | 1.00B |
Important Dates
The next estimated earnings date is Thursday, November 20, 2025.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | Aug 28, 2025 |
Share Statistics
Dr. Martens has 966.37 million shares outstanding. The number of shares has decreased by -1.17% in one year.
| Current Share Class | 966.37M |
| Shares Outstanding | 966.37M |
| Shares Change (YoY) | -1.17% |
| Shares Change (QoQ) | +6.06% |
| Owned by Insiders (%) | 0.90% |
| Owned by Institutions (%) | 49.89% |
| Float | 506.51M |
Valuation Ratios
The trailing PE ratio is 167.13 and the forward PE ratio is 18.32.
| PE Ratio | 167.13 |
| Forward PE | 18.32 |
| PS Ratio | 0.96 |
| PB Ratio | 2.06 |
| P/TBV Ratio | 8.17 |
| P/FCF Ratio | 4.02 |
| P/OCF Ratio | 3.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.89, with an EV/FCF ratio of 5.34.
| EV / Earnings | 222.98 |
| EV / Sales | 1.27 |
| EV / EBITDA | 7.89 |
| EV / EBIT | 16.53 |
| EV / FCF | 5.34 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 1.10.
| Current Ratio | 2.59 |
| Quick Ratio | 1.37 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | 2.15 |
| Interest Coverage | 2.01 |
Financial Efficiency
Return on equity (ROE) is 1.23% and return on invested capital (ROIC) is 4.70%.
| Return on Equity (ROE) | 1.23% |
| Return on Assets (ROA) | 4.12% |
| Return on Invested Capital (ROIC) | 4.70% |
| Return on Capital Employed (ROCE) | 8.30% |
| Revenue Per Employee | 335,434 |
| Profits Per Employee | 1,917 |
| Employee Count | 2,348 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.25 |
Taxes
In the past 12 months, Dr. Martens has paid 4.30 million in taxes.
| Income Tax | 4.30M |
| Effective Tax Rate | 48.86% |
Stock Price Statistics
The stock price has increased by +16.04% in the last 52 weeks. The beta is 0.18, so Dr. Martens's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | +16.04% |
| 50-Day Moving Average | 76.23 |
| 200-Day Moving Average | 65.57 |
| Relative Strength Index (RSI) | 50.21 |
| Average Volume (20 Days) | 810,706 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Martens had revenue of GBP 787.60 million and earned 4.50 million in profits. Earnings per share was 0.00.
| Revenue | 787.60M |
| Gross Profit | 511.70M |
| Operating Income | 60.70M |
| Pretax Income | 8.80M |
| Net Income | 4.50M |
| EBITDA | 75.70M |
| EBIT | 60.70M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 155.90 million in cash and 404.10 million in debt, giving a net cash position of -248.20 million or -0.26 per share.
| Cash & Cash Equivalents | 155.90M |
| Total Debt | 404.10M |
| Net Cash | -248.20M |
| Net Cash Per Share | -0.26 |
| Equity (Book Value) | 366.40M |
| Book Value Per Share | 0.38 |
| Working Capital | 252.30M |
Cash Flow
In the last 12 months, operating cash flow was 196.30 million and capital expenditures -8.40 million, giving a free cash flow of 187.90 million.
| Operating Cash Flow | 196.30M |
| Capital Expenditures | -8.40M |
| Free Cash Flow | 187.90M |
| FCF Per Share | 0.19 |
Margins
Gross margin is 64.97%, with operating and profit margins of 7.71% and 0.57%.
| Gross Margin | 64.97% |
| Operating Margin | 7.71% |
| Pretax Margin | 1.12% |
| Profit Margin | 0.57% |
| EBITDA Margin | 9.61% |
| EBIT Margin | 7.71% |
| FCF Margin | 23.86% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.26%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 3.26% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 211.11% |
| Buyback Yield | 1.17% |
| Shareholder Yield | 4.46% |
| Earnings Yield | 0.60% |
| FCF Yield | 24.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dr. Martens has an Altman Z-Score of 4.97 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.97 |
| Piotroski F-Score | 5 |